The value of the NMP22 test for superficial bladder cancer diagnosis and follow-up.

Dogan, Caner; Pelit, Eyyüp Sabri; Yildirim, Asif; Zemheri, Itir Ebru; Çanakci, Cengiz; Basok, Erem Kaan; Çaskurlu, Turhan

Dogan, Caner; Pelit, Eyyüp Sabri; Yildirim, Asif; Zemheri, Itir Ebru; Çanakci, Cengiz; Basok, Erem Kaan; Çaskurlu, Turhan.

Afiliación

Dogan C; Department of Urology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Pelit ES; Department of Urology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Yildirim A; Department of Urology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Zemheri IE; Department of Pathology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Çanakci C; Department of Urology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Basok EK; Department of Urology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.
Çaskurlu T; Department of Urology, Faculty of Medicine, Istanbul Medeniyet University, Istanbul, Turkey.

Turk J Urol ; 39(3): 137-42, 2013 Sep.

Article en En | MEDLINE | ID: mdl-26328097

Palabras clave

Bladder cancer; NMP22; cytology; detection; surveillance; tumor marker

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Turk J Urol Año: 2013 Tipo del documento: Article País de afiliación: Turquía

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google